Millennium Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
921,965
+306,847
| +50% | +$4.02M | 0.01% | 1479 |
|
|
2025
Q1 | $13.5M | Sell |
615,118
-273,850
| -31% | -$6.02M | 0.01% | 1316 |
|
|
2024
Q4 | $23.7M | Sell |
888,968
-98,062
| -10% | -$2.62M | 0.01% | 987 |
|
|
2024
Q3 | $26.3M | Sell |
987,030
-158,476
| -14% | -$4.23M | 0.01% | 924 |
|
|
2024
Q2 | $20.6M | Buy |
1,145,506
+613,251
| +115% | +$11M | 0.01% | 1055 |
|
|
2024
Q1 | $9.71M | Buy |
532,255
+400,900
| +305% | +$7.31M | ﹤0.01% | 1517 |
|
|
2023
Q4 | $1.44M | Buy |
131,355
+95,462
| +266% | +$1.04M | ﹤0.01% | 2629 |
|
|
2023
Q3 | $206K | Buy |
+35,893
| New | +$206K | ﹤0.01% | 3599 |
|
|
2023
Q1 | – | Sell |
-42,208
| Closed | -$377K | – | 4650 |
|
|
2022
Q4 | $377K | Sell |
42,208
-116,286
| -73% | -$1.04M | ﹤0.01% | 3783 |
|
|
2022
Q3 | $1.56M | Buy |
158,494
+91,188
| +135% | +$898K | ﹤0.01% | 3056 |
|
|
2022
Q2 | $536K | Buy |
67,306
+6,314
| +10% | +$50.3K | ﹤0.01% | 3839 |
|
|
2022
Q1 | $592K | Buy |
+60,992
| New | +$592K | ﹤0.01% | 3966 |
|
|
2021
Q2 | – | Sell |
-60,077
| Closed | -$1.95M | – | 5085 |
|
|
2021
Q1 | $1.95M | Buy |
+60,077
| New | +$1.95M | ﹤0.01% | 2836 |
|